Summary
To investigate the relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene, RASSF1A protein expression was measured by Western blotting in 10 specimens of normal bladder tissues and 23 specimens of bladder transitional cell carcinoma (BTCC). The promoter methylation in BTCC and normal bladder tissues was detected by methylation-specific PCR (MSP). The results showed that the expression level of RASSF1A protein was significantly lower in BTCC tissues than that in normal bladder tissues. However, it was not correlated with its clinical stages and pathological grades. The frequency of promoter methylation of RASSF1A gene was higher in BTCC tissues than that in normal bladder tissues. In 14 patients with the aberrant promoter methylation, 13 showed loss or low expression of RASSF1A protein. It is concluded that RASSF1A gene promoter methylation may contribute to the low level or loss of RASSF1A protein expression, the inactivation of RASSF1A gene and the genesis of BTCC. But, it may bear no correlation with its clinical stages and pathological grades.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Spugnardi M, Tommasi S, Dammann R et al. Epigenetic inactivation of RAS association domain family Protein1 (RASSF1A)in malignant cutaneous melanoma. Cancer Res, 2003,63(7):1639–1643
Schagdarsurengin U, Gimm O, Hoang-Vu C et al. Frequent epigenetic silencing of the CPG island Promoter of RASSF1A in thyroid carcinoma. Cancer Res, 2002,62(13):3698–3701
Dammann R, Yang G, Pfeifer G P. Hypermethylation of the CPG island of Ras association domain family 1 A (RASSF1A), a Putative tumor suppressor gene from the 3P21.3 locus, occurs in a large percentage of human breast Cancer. Cancer Res, 2001,61:3105–3109
Dammann R, Li C, Yoon J H et al. Epigenetic inactivation of a Ras association domain family Protein from the Lung tumor suppressor Locus 3P21.3. Net Genet, 2002,25(3):315–319
Shivakumar L, Minna I, Sakamaki T et al. The RASSF1A tumor suppressor block cell cycle Progression and inhibits cyclin D1 accumulation. MoL Cell Biol, 2002,22(12):4309–4318
Vos M D, Ellis C A, Bell A et al. Ras use the novel tumor suppressor RASSF1A as an effector to mediate apoptosis. J Biol Chem, 2000,275:35669–35672
Wang Y M, Kim Y H, Kim J S et al. RASSF1A suppresses the C-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res, 2005,65(9):3682–3690
Dallol A, Agathanggelou A, Fenton S L et al. RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res, 2004,64(12):4112–4116
Vos M D, Martinez A, Elam C et al. A role for the RASSF1A tumor suppressor in the regulation of tublin polgmerization and genomic stability. Cancer Res, 2004,64(12):4244–4250
Cheng J C, Matsen C B, Gonzales F A et al. Inhibition of DNA methylation and reactivation of Silence genes by Zebularine. J Natl Cancer Inst, 2003,95:399–409
Author information
Authors and Affiliations
Corresponding author
Additional information
Jianting HU, male, born in 1965, M.D., Ph.D.
This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30571858).
Rights and permissions
About this article
Cite this article
Hu, J., Li, H., Shi, T. et al. Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 28, 182–184 (2008). https://doi.org/10.1007/s11596-008-0217-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-008-0217-3